PT86224A - Verbesserte metallhaltige pharmazeutika - Google Patents
Verbesserte metallhaltige pharmazeutikaInfo
- Publication number
- PT86224A PT86224A PT86224A PT8622487A PT86224A PT 86224 A PT86224 A PT 86224A PT 86224 A PT86224 A PT 86224A PT 8622487 A PT8622487 A PT 8622487A PT 86224 A PT86224 A PT 86224A
- Authority
- PT
- Portugal
- Prior art keywords
- pharmaceuticals
- improved metallic
- metallic
- improved
- additive
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/547—Chelates, e.g. Gd-DOTA or Zinc-amino acid chelates; Chelate-forming compounds, e.g. DOTA or ethylenediamine being covalently linked or complexed to the pharmacologically- or therapeutically-active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6887—Antibody-chelate conjugates using chelates for therapeutic purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/90—In vivo diagnostic or in vivo test agent which contains an additional ingredient to reduce the toxicity or side effects of the active ingredient
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3640708A DE3640708C2 (de) | 1986-11-28 | 1986-11-28 | Verbesserte metallhaltige Pharmazeutika |
Publications (2)
Publication Number | Publication Date |
---|---|
PT86224A true PT86224A (de) | 1987-12-01 |
PT86224B PT86224B (pt) | 1990-11-07 |
Family
ID=6315011
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT86224A PT86224B (pt) | 1986-11-28 | 1987-11-26 | Processo para a preparacao de composicoes farmaceuticas melhoradas contendo metais |
Country Status (16)
Country | Link |
---|---|
US (4) | US5098692A (pt) |
EP (1) | EP0270483B2 (pt) |
JP (1) | JPH0662444B2 (pt) |
AT (1) | ATE78705T1 (pt) |
AU (1) | AU607727B2 (pt) |
CA (1) | CA1322156C (pt) |
DE (2) | DE3640708C2 (pt) |
DK (1) | DK168728B1 (pt) |
ES (1) | ES2051768T5 (pt) |
GR (2) | GR3005319T3 (pt) |
IE (1) | IE61663B1 (pt) |
IL (1) | IL84598A (pt) |
NO (1) | NO173976C (pt) |
NZ (1) | NZ222677A (pt) |
PT (1) | PT86224B (pt) |
ZA (1) | ZA878952B (pt) |
Families Citing this family (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5219553A (en) * | 1986-08-04 | 1993-06-15 | Salutar, Inc. | Composition of a n-carboxymethylated tetraazacyclododecane chelating agent, a paramagnetic metal and excess calcium ions for MRI |
US5039512A (en) * | 1986-08-04 | 1991-08-13 | Salutar, Inc. | NMR imaging with paramagnetic polyvalent metal salts of poly-(acid-alkylene-amino)-alkanes |
DE3640708C2 (de) * | 1986-11-28 | 1995-05-18 | Schering Ag | Verbesserte metallhaltige Pharmazeutika |
US5399340A (en) * | 1987-09-24 | 1995-03-21 | Schering Aktiengesellschaft | Use of amide complex compounds |
US5137711A (en) † | 1988-07-19 | 1992-08-11 | Mallickrodt Medical, Inc. | Paramagnetic dtpa and edta alkoxyalkylamide complexes as mri agents |
US5314681A (en) * | 1988-12-23 | 1994-05-24 | Nycomed Innovation Ab | Composition of positive and negative contrast agents for electron spin resonance enhanced magnetic resonance imaging |
GB8900719D0 (en) * | 1989-01-13 | 1989-03-08 | Nycomed As | Compounds |
US5364613A (en) * | 1989-04-07 | 1994-11-15 | Sieving Paul F | Polychelants containing macrocyclic chelant moieties |
US5087440A (en) * | 1989-07-31 | 1992-02-11 | Salutar, Inc. | Heterocyclic derivatives of DTPA used for magnetic resonance imaging |
US5843399A (en) * | 1990-04-06 | 1998-12-01 | Schering Aktiengesellschaft | DTPA monoamides for MRI |
DE4011684A1 (de) | 1990-04-06 | 1991-10-10 | Schering Ag | Dtpa-monoamide, diese verbindungen enthaltende pharmazeutische mittel, ihre verwendung und verfahren zu deren herstellung |
US5368840A (en) * | 1990-04-10 | 1994-11-29 | Imarx Pharmaceutical Corp. | Natural polymers as contrast media for magnetic resonance imaging |
CA2039399C (en) * | 1990-04-25 | 2000-09-05 | C. Allen Chang | Dual functioning excipient for metal chelate contrast agents |
US5439913A (en) | 1992-05-12 | 1995-08-08 | Schering Aktiengesellschaft | Contraception method using competitive progesterone antagonists and novel compounds useful therein |
US5550160A (en) * | 1992-07-31 | 1996-08-27 | Australian Nuclear Science & Technology Organization | Metal complexes of hydroxyaryl containing aminocarboxylic acid chelating agents |
US5807535A (en) * | 1992-07-31 | 1998-09-15 | Australian Nuclear Science & Technology Organisation | Metal complexes of hydroxyaryl containing aminocarboxylic acid chelating agents |
US5346997A (en) * | 1992-08-26 | 1994-09-13 | Murphy James G | Agents for complexing sodium under biological conditions |
DE19543077C2 (de) * | 1995-11-13 | 1997-10-16 | Schering Ag | Verwendung von gashaltigen Metallkomplexen als Ultraschallkontrastmittel |
US5932229A (en) * | 1996-04-25 | 1999-08-03 | Avon Products, Inc. | Oxa diacids and related compounds for treating skin conditions |
US5834513A (en) * | 1996-04-25 | 1998-11-10 | Avon Products, Inc. | Oxa diacids and related compounds for treating skin conditions |
US5847003A (en) | 1996-06-04 | 1998-12-08 | Avon Products, Inc. | Oxa acids and related compounds for treating skin conditions |
US6361759B1 (en) | 1998-05-26 | 2002-03-26 | Wisconsin Alumni Research Foundation | MR signal-emitting coatings |
US6896874B2 (en) * | 1998-05-26 | 2005-05-24 | Wisconsin Alumni Research Foundation | MR-signal emitting coatings |
AU6985400A (en) * | 1999-05-12 | 2000-12-12 | Laser- Und Medizin-Technologie Gmbh Berlin | Radiotherapy device |
US6559330B1 (en) | 1999-09-09 | 2003-05-06 | Schering Aktiengesellschaft | Calcium complex of [[(4r)-4-[bis{carboxy-.kappa.o)methyl]amino-.kappa.n]-6,9-bis[(carboxy.kappa.o)methyl]-1-[(4,4-diphenylcyclohexyl)oxy]-1-hydroxy-2-oxa-6,9-diaza-1-phosphaundecan-11-ylic-acid-.kappa.n6,.kappa.n9,.kappa.011]1-oxidato(6-)]-, hexahydrogen, its salts, pharmaceutical agents that contain these complexes, their use in treatment and as additives in diagnosis, as well as processes for the production of the complexes and agents |
US20030203879A1 (en) * | 1999-09-09 | 2003-10-30 | Schering Ag | Calcium complex of [[(4R)-4-[bis[(carboxy-.kappa.O)methyl]amino-.kappa.n]-6,9-bis[(carboxy.kappa.O)methyl]-1-[(4,4-diphenylcyclohexy)oxy]-1-hydroxy-2-oxa-6,9-diaza-1-phosphaundecan-11-ylic-acid-.kappa.N6,.Kappa.N9,.Kappa 011]1-oxidato(6-)]-, hexahydrogen, its salts, pharmaceutical agents that contain these complexes, their use in treatment and as additives in diagnosis, as well as processes for the production of the complexes and agents |
US7189705B2 (en) | 2000-04-20 | 2007-03-13 | The University Of British Columbia | Methods of enhancing SPLP-mediated transfection using endosomal membrane destabilizers |
JP2004534808A (ja) * | 2001-06-22 | 2004-11-18 | シエーリング アクチエンゲゼルシャフト | (エチレン)−(プロピレン)−トリアミン五酢酸誘導体類、それらの製造方法、及び医薬剤の製造のためへのそれらの使用 |
WO2004006934A2 (de) * | 2002-07-10 | 2004-01-22 | Hans Robert Kalbitzer | 1,4,7,10-tetraazacyclododecane als modulatoren des guanin-nukleotid bindenden roteins zur behandlung von tumoren |
US20040253292A1 (en) * | 2003-04-23 | 2004-12-16 | Wisconsin Alumni Research Foundation | MR-signal emitting coatings |
US20070156042A1 (en) * | 2005-12-30 | 2007-07-05 | Orhan Unal | Medical device system and method for tracking and visualizing a medical device system under MR guidance |
US8457712B2 (en) * | 2005-12-30 | 2013-06-04 | Wisconsin Alumni Research Foundation | Multi-mode medical device system and methods of manufacturing and using same |
EP2010143B1 (en) | 2006-03-17 | 2015-08-12 | Johnson & Johnson Vision Care, Inc. | Stabilized ophthalmic compositions comprising oxidatively unstable components |
US8532742B2 (en) * | 2006-11-15 | 2013-09-10 | Wisconsin Alumni Research Foundation | System and method for simultaneous 3DPR device tracking and imaging under MR-guidance for therapeutic endovascular interventions |
US20080183070A1 (en) * | 2007-01-29 | 2008-07-31 | Wisconsin Alumni Research Foundation | Multi-mode medical device system with thermal ablation capability and methods of using same |
US8412306B2 (en) * | 2007-02-28 | 2013-04-02 | Wisconsin Alumni Research Foundation | Voltage standing wave suppression for MR-guided therapeutic interventions |
US8147802B2 (en) * | 2007-09-28 | 2012-04-03 | General Electric Company | Chelator-functionalized nanoparticles |
FR2927539B1 (fr) * | 2008-02-19 | 2010-07-30 | Guerbet Sa | Procede de preparation d'une formulation pharmaceutique d'agents de contraste. |
US20090208421A1 (en) * | 2008-02-19 | 2009-08-20 | Dominique Meyer | Process for preparing a pharmaceutical formulation of contrast agents |
FR2945448B1 (fr) | 2009-05-13 | 2012-08-31 | Guerbet Sa | Procede de preparation d'une formulation pharmaceutique de chelate de lanthanide sous forme de poudre. |
DE102009053171B4 (de) | 2009-11-04 | 2011-07-21 | Bayer Schering Pharma Aktiengesellschaft, 13353 | Verfahren zur Herstellung des Calcium-Komplexes von Dihydroxy-hydroxy-methylpropyl-tetraazacyclododecan-triessigsäure (Calcobutrol) |
NO331773B1 (no) | 2009-12-18 | 2012-03-26 | Ge Healthcare As | Mangankelater, sammensetninger omfattende slike og anvendelse av disse som kontrastmidler for magnettomografi (MR) |
DE102010023890A1 (de) | 2010-06-11 | 2011-12-15 | Bayer Schering Pharma Aktiengesellschaft | Verfahren zur Herstellung kristalliner 3,6,9-Triaza-3,6,9-tris(carboxymethyl)-4-(ethoxybenzyl)-undecandinsäure und die Verwendung zur Herstellung von Primovist |
JP2013531643A (ja) | 2010-06-11 | 2013-08-08 | バイエル・インテレクチユアル・プロパテイー・ゲー・エム・ベー・ハー | 結晶質3,6,9−トリアザ−3,6,9−トリス(カルボキシメチル)−4−(4−エトキシベンジル)ウンデカン二酸を調製する方法及びプリモビスト(Primovist)(登録商標)を製造するための方法 |
WO2012136813A2 (en) | 2011-04-07 | 2012-10-11 | Universitetet I Oslo | Agents for medical radar diagnosis |
PE20141325A1 (es) | 2011-04-21 | 2014-10-08 | Bayer Ip Gmbh | Preparacion de gadobutrol de alta pureza |
EP2786768A1 (en) | 2013-04-04 | 2014-10-08 | Agfa Healthcare | Process for preparing a material comprising a macrocyclic ligand and for producing a pharmaceutical formulation comprising said ligand with a lanthanide |
HUE033219T2 (en) | 2013-04-26 | 2017-11-28 | Guerbet Sa | Contrast medium preparation and related preparation process |
AT516104B1 (de) | 2014-07-31 | 2016-08-15 | Sanochemia Pharmazeutika Ag | Verfahren zum Herstellen einer flüssigen pharmazeutischen Zubereitung |
GB201421162D0 (en) | 2014-11-28 | 2015-01-14 | Ge Healthcare As | Lanthanide complex formulations |
DE102015013939A1 (de) | 2015-09-15 | 2017-03-16 | be imaging GmbH | Verfahren zur Herstellung von Gadotersäure (Gd-DOTA)- Komplexen |
GB201610738D0 (en) | 2016-06-20 | 2016-08-03 | Ge Healthcare As | Chelate compounds |
IL265536B (en) | 2016-09-27 | 2022-07-01 | Bayer Pharma AG | A method for the production of a crystalline form of the a modification of calcobuterol |
WO2018069179A1 (en) | 2016-10-12 | 2018-04-19 | T2Pharma Gmbh | Method of preparing formulations of lanthanide metal complexes of macrocyclic chelates |
WO2018069176A1 (en) | 2016-10-12 | 2018-04-19 | T2Pharma Gmbh | Method of preparing formulations of lanthanide metal complexes of macrocyclic chelates |
CN110035996B (zh) | 2016-11-28 | 2022-08-09 | 拜耳医药股份公司 | 用于磁共振成像的新型高弛豫性钆螯合物 |
ES2813077T3 (es) | 2016-12-21 | 2021-03-22 | Ge Healthcare As | Compuestos quelatos de manganeso basados en macrociclo de tetraazabiciclo adecuados como agentes de imagen de IRM |
EP3728168B1 (en) | 2017-12-20 | 2022-03-30 | General Electric Company | Anionic chelate compounds |
AT521001B1 (de) | 2018-02-23 | 2020-10-15 | Sanochemia Pharmazeutika Ag | Herstellungsverfahren für ein Kontrastmittel |
KR20210095168A (ko) | 2018-11-23 | 2021-07-30 | 바이엘 악티엔게젤샤프트 | 조영 매체의 제형 및 그의 제조 방법 |
FR3091873B1 (fr) | 2019-01-17 | 2020-12-25 | Guerbet Sa | Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification |
CN114845990A (zh) | 2019-12-20 | 2022-08-02 | 伯拉考成像股份公司 | 钙bopta配合物 |
GB201919073D0 (en) | 2019-12-20 | 2020-02-05 | Ge Healthcare As | Novel manufacturing process |
WO2022013454A1 (fr) | 2020-07-17 | 2022-01-20 | Guerbet | Procede de preparation d'un ligand chelateur derive de pcta |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB736432A (en) * | 1952-01-16 | 1955-09-07 | Dow Chemical Co | Improvements in or relating to compositions for the x-ray visualization of the organs and cavities of the body |
US3033757A (en) * | 1959-04-08 | 1962-05-08 | Mallinckrodt Chemical Works | X-ray contrast agents |
US3175952A (en) * | 1963-05-29 | 1965-03-30 | Sterling Drug Inc | Aqueous radiopaque solutions containing sodium and calcium ions |
US3633688A (en) * | 1970-02-13 | 1972-01-11 | Albert G Bodine | Torsional rectifier drilling device |
US4432963A (en) * | 1978-07-31 | 1984-02-21 | Mallinckrodt, Inc. | Radiographic scanning agent |
US4247534A (en) * | 1978-07-31 | 1981-01-27 | The Procter & Gamble Company | Radiographic scanning agent |
DE2943498C2 (de) * | 1979-10-27 | 1983-01-27 | Henkel KGaA, 4000 Düsseldorf | Verfahren zur Herstellung von 3-Amino-1-hydroxypropan-1,1-diphosphonsäure |
CA1178951A (en) * | 1980-03-18 | 1984-12-04 | Claude F. Meares | Chelating agents and method |
US4647447A (en) * | 1981-07-24 | 1987-03-03 | Schering Aktiengesellschaft | Diagnostic media |
US4957939A (en) * | 1981-07-24 | 1990-09-18 | Schering Aktiengesellschaft | Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging |
DE3129906C3 (de) * | 1981-07-24 | 1996-12-19 | Schering Ag | Paramagnetische Komplexsalze, deren Herstellung und Mittel zur Verwendung bei der NMR-Diagnostik |
US4478816A (en) * | 1982-06-07 | 1984-10-23 | Georgetown University | Rare earth/chelating agent complex for digital fluoroscopy |
NL194579C (nl) * | 1983-01-21 | 2002-08-05 | Schering Ag | Diagnostisch middel. |
DE3324235A1 (de) * | 1983-07-01 | 1985-01-10 | Schering AG, 1000 Berlin und 4709 Bergkamen | Neue komplexbildner, komplexe und komplexsalze |
GB8413772D0 (en) * | 1984-05-30 | 1984-07-04 | Nyegaard & Co As | Chemical compounds |
US4749560A (en) * | 1984-08-13 | 1988-06-07 | Research Corporation | Metal organo phosphorous compounds for NMR analysis |
SE465907B (sv) * | 1984-11-01 | 1991-11-18 | Nyegaard & Co As | Diagnosticeringsmedel innehaallande en paramagnetisk metall |
US5082649A (en) * | 1987-06-30 | 1992-01-21 | Mallinckrodt Medical, Inc. | Method for enhancing the safety of metal-ligand chelates as magnetic resonance imaging agents by addition of calcium ions |
US4826673A (en) * | 1985-01-09 | 1989-05-02 | Mallinckrodt, Inc. | Methods and compositions for enhancing magnetic resonance imaging |
US4980148A (en) * | 1985-02-06 | 1990-12-25 | Mallinckrodt, Inc. | Methods for enhancing magnetic resonance imaging |
US4746507A (en) * | 1985-04-02 | 1988-05-24 | Salutar, Inc. | EDHPA based contrast agents for MR imaging, apparatus and methods |
US5039512A (en) * | 1986-08-04 | 1991-08-13 | Salutar, Inc. | NMR imaging with paramagnetic polyvalent metal salts of poly-(acid-alkylene-amino)-alkanes |
US5219553A (en) * | 1986-08-04 | 1993-06-15 | Salutar, Inc. | Composition of a n-carboxymethylated tetraazacyclododecane chelating agent, a paramagnetic metal and excess calcium ions for MRI |
IL83966A (en) * | 1986-09-26 | 1992-03-29 | Schering Ag | Amides of aminopolycarboxylic acids and pharmaceutical compositions containing them |
DE3640708C2 (de) * | 1986-11-28 | 1995-05-18 | Schering Ag | Verbesserte metallhaltige Pharmazeutika |
JP2854905B2 (ja) * | 1988-09-27 | 1999-02-10 | サリユーター・インコーポレイテツド | キレート組成物 |
US5078986A (en) * | 1989-02-15 | 1992-01-07 | Mallinckrodt Medical, Inc. | Method for enhancing magnetic resonance imaging using an image altering agent containing an excess of chelating agent |
JPH04311288A (ja) * | 1991-04-09 | 1992-11-04 | Daido Denki Kogyo Kk | 通行者数検出装置 |
JPH09311288A (ja) * | 1996-05-16 | 1997-12-02 | Ricoh Co Ltd | 光走査装置 |
-
1986
- 1986-11-28 DE DE3640708A patent/DE3640708C2/de not_active Expired - Lifetime
-
1987
- 1987-11-10 DK DK588487A patent/DK168728B1/da not_active IP Right Cessation
- 1987-11-23 DE DE87730155T patent/DE3780776D1/de not_active Expired - Lifetime
- 1987-11-23 EP EP87730155A patent/EP0270483B2/de not_active Expired - Lifetime
- 1987-11-23 AT AT87730155T patent/ATE78705T1/de not_active IP Right Cessation
- 1987-11-23 ES ES87730155T patent/ES2051768T5/es not_active Expired - Lifetime
- 1987-11-25 IL IL84598A patent/IL84598A/xx not_active IP Right Cessation
- 1987-11-26 PT PT86224A patent/PT86224B/pt unknown
- 1987-11-27 ZA ZA878952A patent/ZA878952B/xx unknown
- 1987-11-27 CA CA000553024A patent/CA1322156C/en not_active Expired - Lifetime
- 1987-11-27 NO NO874971A patent/NO173976C/no not_active IP Right Cessation
- 1987-11-27 AU AU81889/87A patent/AU607727B2/en not_active Expired
- 1987-11-27 NZ NZ222677A patent/NZ222677A/xx unknown
- 1987-11-27 JP JP62297907A patent/JPH0662444B2/ja not_active Expired - Lifetime
- 1987-11-27 IE IE322287A patent/IE61663B1/en not_active IP Right Cessation
-
1990
- 1990-10-22 US US07/601,594 patent/US5098692A/en not_active Expired - Lifetime
-
1992
- 1992-07-30 GR GR920401656T patent/GR3005319T3/el unknown
-
1995
- 1995-02-14 US US08/388,902 patent/US5876695A/en not_active Expired - Fee Related
-
1996
- 1996-02-15 GR GR960400210T patent/GR3019002T3/el unknown
-
2003
- 2003-06-16 US US10/461,384 patent/US20030206858A1/en not_active Abandoned
-
2006
- 2006-03-23 US US11/386,640 patent/US20060165591A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US5876695A (en) | 1999-03-02 |
EP0270483B2 (de) | 1996-02-14 |
IE873222L (en) | 1988-05-28 |
NZ222677A (en) | 1990-07-26 |
IE61663B1 (en) | 1994-11-16 |
US20060165591A1 (en) | 2006-07-27 |
ES2051768T5 (es) | 1996-06-16 |
DK588487A (da) | 1988-05-29 |
DK588487D0 (da) | 1987-11-10 |
GR3019002T3 (en) | 1996-05-31 |
JPH0662444B2 (ja) | 1994-08-17 |
PT86224B (pt) | 1990-11-07 |
DE3640708C2 (de) | 1995-05-18 |
NO874971L (no) | 1988-05-30 |
ZA878952B (en) | 1988-07-27 |
GR3005319T3 (en) | 1993-05-24 |
CA1322156C (en) | 1993-09-14 |
AU8188987A (en) | 1988-06-02 |
IL84598A0 (en) | 1988-04-29 |
NO874971D0 (no) | 1987-11-27 |
EP0270483B1 (de) | 1992-07-29 |
ATE78705T1 (de) | 1992-08-15 |
DE3780776D1 (de) | 1992-09-03 |
EP0270483A2 (de) | 1988-06-08 |
DE3640708A1 (de) | 1988-06-09 |
EP0270483A3 (en) | 1989-12-27 |
IL84598A (en) | 1991-01-31 |
AU607727B2 (en) | 1991-03-14 |
ES2051768T3 (es) | 1994-07-01 |
NO173976C (no) | 1994-03-02 |
JPS63145239A (ja) | 1988-06-17 |
NO173976B (no) | 1993-11-22 |
US5098692A (en) | 1992-03-24 |
DK168728B1 (da) | 1994-05-30 |
US20030206858A1 (en) | 2003-11-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT86224A (de) | Verbesserte metallhaltige pharmazeutika | |
DE68924832D1 (de) | Metallischer dichtungsring. | |
NL186912C (nl) | Kleefmiddelsamenstelling en voorwerpen die de kleefmiddelsamenstelling bevatten. | |
NL185219C (nl) | Kleefmiddelsamenstelling en voorwerpen die de kleefmiddelsamenstelling bevatten. | |
IT8222704A0 (it) | Squadra per carpenteria e tracciatura. | |
DE69015236D1 (de) | Elektro-optisches Sender-Empfänger-Bauelement in einem Gehäuse. | |
NO903984L (no) | Foringsroerkopling med metalltetning. | |
JPS5228546A (en) | Retainer agent or flocculating agent based on polyacrylamide | |
DE69013366D1 (de) | Fruchtbarkeitsanalysegerät. | |
ES517532A0 (es) | Procedimiento para la cementacion de piezas metalicas. | |
IT8022553A0 (it) | Beta-ottamolibdato di ammelinio e composizione che lo contiene. | |
IT7822403A0 (it) | Metodo di lubrificazione e composizione con composti mxy 3. | |
DE3772583D1 (de) | Kastenfoermiges bauelement. | |
IT7830974A0 (it) | Composti 2-benzazepinici sostituiti in posizione 8 e/o in posizione 9. | |
ES2019295B3 (es) | Polvos de cementacion. | |
DE58901402D1 (de) | Metallische flachdichtung. | |
DE3782799D1 (de) | Fluessigmetall-ionenquelle und -legierung. | |
IT8022495A0 (it) | Tripentilammonio decamolibdato e composizione che lo contiene. | |
NL7802479A (nl) | Anti-coccidiose en ovo-larvicide middelen. | |
IT7821611A0 (it) | Dispositivo per l'applicazione di guarnizioni di tenuta in profilati di minuteria metallica. | |
IT8119662A0 (it) | Bracciale e dispositivo di chiusura per lo stesso. | |
ES263168Y (es) | "panel metalico perfeccionado". | |
DE68916802D1 (de) | Metalldichtung. | |
IT1210210B (it) | Tavola metallica con botola. | |
ES285527U (es) | Estante perfeccionado |